EZH2 and urinary bladder cancer: For example, as a part of the complex, lncRNA H19 associated with EZH2 enhancer and inhibited E-cad expression, which resulted in the activation of the Wnt/β-catenin pathway enhancing bladder cancer metastasis [11].